Compare studies and check their requirements with the research team.
This study is completed in the United States. It is testing tolerability and Efficacy of Cannabidiol on Tremor for Schizophrenia.
In United StatesThis study is completed in the United States. It is testing varenicline for schizophrenia.
In United StatesThis study is completed in the United States. It focuses on Bipolarity.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis study was terminated in the United States. It is testing adverse Events of Fosigotifator for depression.
In United StatesThis study is completed in the United States, in the United Kingdom, in Bulgaria, .... It is testing KarXT for schizophrenia.
In United StatesThis study is completed in the United States. It is testing KarXT for schizophrenia.
In United StatesThis study is completed in the United States and in Ukraine. It is testing KarXT for schizophrenia.
In United States
This study was withdrawn in the United States. It is testing Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy for treatment-resistant depression.
In United StatesThis study is completed in the United States. It is testing Safety and Efficacy of KarXT for schizophrenia.
In United StatesThis study is completed in the United States. It is testing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 for schizophrenia.
In United StatesThis study was terminated in the United States. It is testing clinical Utility of Antipsychotic Medication Levels for Schizophrenia.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.